ALEXANDRIA, Virginia, April 24 -- Three inventors Konstantinos Kiakos, Vienna, Austria; John A. Hartley, London, United Kingdom; and Moses Namfong Lee, Vancouver, Washington, have been awarded a patent (No. US 11964943 B2, initially filed May 19, 2020) for "3,5-diarylidenyl-n-substituted-piperid-4-one-derived inhibitors of Stat3 pathway activity and uses thereof." . . .